Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Progestin-Primed Ovarian Stimulation Versus Gonadotrophin-Releasing Hormone Antagonist for Patients Undergoing Assisted Reproductive Technology: a Randomized Clinical Trial

NCT06868576 is registered in ClinicalTrials.gov with Kasr El Aini Hospital as lead sponsor.

NCT NCT06868576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06868576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Progestin-Primed Ovarian Stimulation Versus Gonadotrophin-Releasing Hormone Antagonist for Patients Undergoing Assisted Reproductive Technology: a Randomized Clinical Trial
Lead sponsor
Kasr El Aini Hospital
Phase
Phase 3
Overall status
Completed
Start date
January 3, 2023
Completion date
February 28, 2025
Enrollment
328 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

assisted reproductive techniques, gnrh antagonist, ppos